New methods to determine the CNS effects of antigeriatric compounds: EEG topography and glucose use

M.S. Buchsbaum(University of California, Irvine), Daniël P. van Kammen(National Institute of Mental Health), Richard Coppola(United States Department of Health and Human Services), J. Cappelletti(National Institute of Mental Health), Anna C. King(National Institute of Mental Health), Francois Regal(National Institute of Mental Health)
Drug Development Research
January 1, 1982
Cited by 29


Related Papers